Liquidia Corp cash flow statement
In fiscal 2025, Liquidia Corp's operations generated −$35.7m of cash; it spent $4.3m on capital projects, leaving free cash flow of −$40.0m.
Cash flow statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −48 | −54 | −34 | −29 | −42 | −93 | −36 | 168 |
| Depreciation and amortisation | 3 | 3 | 6 | 4 | 2 | 2 | 2 | 1 |
| Stock-based pay | 3 | 4 | 7 | 9 | 10 | 19 | 29 | 35 |
| Capital spending | 2 | 1 | 0 | 1 | 1 | 5 | 4 | 17 |
| Free cash flow | −50 | −55 | −34 | −29 | −43 | −98 | −40 | 151 |
| Free cash flow after stock pay | −54 | −59 | −41 | −38 | −53 | −117 | −69 | 116 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −25 | −21 | −31 | −39 | −10 | 44 | 53 | 80 |
| Depreciation and amortisation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 5 | 5 | 7 | 7 | 8 | 7 | 9 | 10 |
| Capital spending | 2 | 1 | 0 | 1 | 1 | 2 | 3 | 11 |
| Free cash flow | −27 | −22 | −31 | −41 | −11 | 42 | 50 | 69 |
| Free cash flow after stock pay | −32 | −27 | −38 | −47 | −19 | 35 | 41 | 59 |
Compare with peers
- Innoviva, Inc. cash flow
- Ironwood Pharmaceuticals Inc cash flow
- Alvotech cash flow
- Xeris Biopharma Holdings, Inc. cash flow
- Evolus, Inc. cash flow
Head to head: INVA vs LQDAIRWD vs LQDAALVO vs LQDA
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies